Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection

  • Authors:
    • Qiang Yan
    • Hao Luo
    • Baoyao Wang
    • Weiguo Sui
    • Guimian Zou
    • Huaizhou Chen
    • Hequn Zou
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Guilin 181st Hospital, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi 541002, P.R. China, Department of Oncology, No. 454 Hospital of the PLA, Nanjing, Jiangsu 210002, P.R. China, Department of Nephrology, Institute of Nephrology and Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China
    Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2217-2224
    |
    Published online on: March 24, 2017
       https://doi.org/10.3892/etm.2017.4261
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Chronic antibody‑mediated rejection (ABMR) is a major cause of the transplant renal interstitial fibrosis and transplanted kidney epithelial cell transdifferentiation is one of the main mechanisms. The transforming growth factor (TGF)‑β1/integrin‑linked kinase (ILK) signaling pathway has a significant role in the epithelial‑mesenchymal transition (EMT) of renal tubular epithelial cells; however, the molecular mechanisms of this process have remained elusive. The present study confirmed that Akt and glycogen synthase kinase (GSK)‑3β, as TGF‑β1 downstream signaling factors, are involved in fibrotic processes caused by kidney disease, which, however, has been rarely reported in the kidney transplant field. Based on the Banff 2009 standard, transplanted kidney specimens were classified according to the fibrosis level. The results showed that with the reduction of the interstitial fibrosis level, E‑cadherin expression was gradually reduced, while α‑smooth muscle actin expression progressively increased. The expression of Akt and GSK‑3β in normal human kidney tissue was not obvious but showed a marked increase with the aggravation of the interstitial fibrosis level, which confirmed the occurrence of EMT during the fibrosis process, and that phosphorylated (p)‑Akt and GSK‑3β have an important role in the EMT process in the transplanted kidney. A correlation analysis of p‑Akt, GSK‑3β, TGF‑β1 and ILK suggested that overexpression of p‑Akt and GSK‑3β may induce and mediate the transdifferentiation of renal tubular epithelial cells to myofibroblasts and that this proceeds via TGFβ1/ILK signaling pathways.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Maluf DG, Mas VR, Archer KJ, Yanek K, Gibney EM, King AL, Cotterell A, Fisher RA and Posner MP: Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med. 14:276–285. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Chapman J: Addressing the challenges for improving long-term outcomes in renal transplantation. Transplant Proc. 40:(10 Suppl). S2–S4. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Robertson H, Ali S, McDonnell BJ, Burt AD and Kirby JA: Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol. 15:390–397. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Mannon RB: Therapeutic targets in the treatment of allograft fibrosis. Am J Transplant. 6:867–875. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Li Y, Yang J, Dai C, Wu C and Liu Y: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest. 112:503–516. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Yan Q, Sui W, Xie S, Chen H, Xie S, Zou G, Guo J and Zou H: Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy. Transpl Immunol. 23:1–5. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, et al: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 10:464–471. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Loupy A, Hill GS, Nochy D and Legendre C: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant. 10:9532010. View Article : Google Scholar

9 

Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 15:1–12. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Lan HY: Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens. 12:25–29. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Yang Y, Guo L, Blattner SM, Mundel P, Kretzler M and Wu C: Formation and phosphorylation of the PINCH-1-integrin linked kinase-alpha-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J Am Soc Nephrol. 16:1966–1976. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Han C, Zou H, Li Q, Wang Y, Shi Y, Lv T, Chen L and Zhou W: Expression of the integrin-linked kinase in a rat kidney model of chronic allograft nephropathy. Cell Biochem Biophys. 61:73–81. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Lee YI, Kwon YJ and Joo CK: Integrin-linked kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun. 316:997–1001. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Kattla JJ, Carew RM, Heljic M, Godson C and Brazil DP: Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol. 295:F215–F225. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA. 95:11211–11216. 1998. View Article : Google Scholar : PubMed/NCBI

16 

Dai C, Yang J and Liu Y: Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem. 278:12537–12545. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Zeng R, Yao Y, Han M, Zhao X, Liu XC, Wei J, Luo Y, Zhang J, Zhou J, Wang S, et al: Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. J Am Soc Nephrol. 19:380–387. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Persad S and Dedhar S: The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev. 22:375–384. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Gong R, Rifai A, Ge Y, Chen S and Dworkin LD: Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK-3Β3beta inactivation in renal tubular epithelial cells. J Biol Chem. 283:7401–7410. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Gong R, Ge Y, Chen S, Liang E, Esparza A, Sabo E, Yango A, Gohh R, Rifai A and Dworkin LD: Glycogen synthase kinase 3beta: A novel marker and modulator of inflammatory injury in chronic renal allograft disease. Am J Transplant. 8:1852–1863. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Kim K, Lu Z and Hay ED: Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int. 26:463–476. 2002. View Article : Google Scholar : PubMed/NCBI

23 

Bijur GN and Jope RS: Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport. 14:2415–2419. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Lee YJ and Han HJ: Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3Β-3Β3beta, Snail1 and beta-catenin in renal proximal tubule cells. Am J Physiol Renal Physiol. 298:F1263–F1275. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R and Dedhar S: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA. 95:4374–4379. 1998. View Article : Google Scholar : PubMed/NCBI

26 

Troussard AA, Tan C, Yoganathan TN and Dedhar S: Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol. 19:7420–7427. 1999. View Article : Google Scholar : PubMed/NCBI

27 

Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene. 19:5444–5452. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Li Q, Liu BC, Lv LL, Ma KL, Zhang XL and Philiip AO: Monocytes induce proximal tubular epithelial-mesenchymal transition through NF-kappa B dependent upregulation of ICAM-1. J Cell Biochem. 112:1585–1592. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Yan Q, Wang B, Sui W, Zou G, Chen H, Xie S and Zou H: Expression of GSK-3Β-3Β3b in renal allograft tissue and its significance in pathogenesis of chronic allograft dysfunction. Diagn Pathol. 7:52012. View Article : Google Scholar : PubMed/NCBI

30 

Runyan CE, Schnaper HW and Poncelet AC: The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem. 279:2632–2639. 2004. View Article : Google Scholar : PubMed/NCBI

31 

Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH and Borkan SC: Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol. 288:F703–F713. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yan Q, Luo H, Wang B, Sui W, Zou G, Chen H and Zou H: Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection. Exp Ther Med 13: 2217-2224, 2017.
APA
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., & Zou, H. (2017). Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection. Experimental and Therapeutic Medicine, 13, 2217-2224. https://doi.org/10.3892/etm.2017.4261
MLA
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., Zou, H."Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection". Experimental and Therapeutic Medicine 13.5 (2017): 2217-2224.
Chicago
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., Zou, H."Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection". Experimental and Therapeutic Medicine 13, no. 5 (2017): 2217-2224. https://doi.org/10.3892/etm.2017.4261
Copy and paste a formatted citation
x
Spandidos Publications style
Yan Q, Luo H, Wang B, Sui W, Zou G, Chen H and Zou H: Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection. Exp Ther Med 13: 2217-2224, 2017.
APA
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., & Zou, H. (2017). Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection. Experimental and Therapeutic Medicine, 13, 2217-2224. https://doi.org/10.3892/etm.2017.4261
MLA
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., Zou, H."Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection". Experimental and Therapeutic Medicine 13.5 (2017): 2217-2224.
Chicago
Yan, Q., Luo, H., Wang, B., Sui, W., Zou, G., Chen, H., Zou, H."Correlation between PKB/Akt, GSK‑3β expression and tubular epithelial‑mesenchymal transition in renal allografts with chronic active antibody‑mediated rejection". Experimental and Therapeutic Medicine 13, no. 5 (2017): 2217-2224. https://doi.org/10.3892/etm.2017.4261
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team